Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Van Andel Research Institute
Dell, Inc.
Information provided by (Responsible Party):
Giselle Sholler, Spectrum Health Hospitals
ClinicalTrials.gov Identifier:
NCT01802567
First received: February 26, 2013
Last updated: May 10, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)